LAKE HILLS PHARMACY FORMULATION

CJC-1295 / Ipamorelin

Modified Growth Hormone Releasing Hormone

Level CLake Hills PharmacyCompounded Formula
CJC-1295 / Ipamorelin

References are being re-verified against PubMed and will return with review dates.

C
Emerging Evidence
Preclinical and animal studies with limited human data

Preclinical and animal studies with limited human data

CJC-1295 is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) that has been modified to increase its half-life and stability. It stimulates the pituitary gland to release growth hormone in a pulsatile manner, mimicking the body's natural GH secretion patterns. Compounded by Lake Hills Pharmacy for anti-aging, body composition improvement, and metabolic enhancement protocols.

Clinically reviewed content

CJC-1295 binds to GHRH receptors in the anterior pituitary gland, triggering the release of growth hormone. The Drug Affinity Complex (DAC) modification extends its half-life to 6-8 days, providing sustained GH elevation. Benefits include: - Increased lean muscle mass - Enhanced fat metabolism - Improved bone density - Better sleep quality - Enhanced recovery and tissue repair - Elevated IGF-1 levels

Clinically reviewed content

Generally well-tolerated. Common effects: - Mild injection site reactions - Transient flushing or headache - Water retention (mild) - Increased hunger - Numbness or tingling (rare)

Serious adverse events are uncommon but include potential for elevated prolactin or changes in glucose metabolism.

Serious Adverse Events: Reports include increased heart rate and systemic vasodilatory reactions. Patients should be monitored for cardiovascular symptoms.

Contraindicated in: - Active malignancy or history of cancer - Diabetic retinopathy - Pregnancy and lactation - Hypersensitivity to CJC-1295 or excipients

Precautions: - Monitor IGF-1 levels - Use caution in diabetes - Assess pituitary function before use - Medical supervision required


• Active cardiovascular disease
• Uncontrolled hypertension
• Recent myocardial infarction

Important safety information above

Administer via subcutaneous injection: - Typical Dose: 1-2 mg per injection - Frequency: 1-3 times per week (due to long half-life) - Timing: Bedtime or pre-workout - Cycle: 8-12 weeks on, 4 weeks off - Injection Sites: Abdomen, thigh, or upper arm - Technique: Rotate sites, use sterile technique

Often combined with Ipamorelin or other GH secretagogues for synergistic effects.

Clinically reviewed content

Lake Hills Pharmacy Formulation

Concentration

1mg CJC-1295 / 1mg Ipamorelin per mL (Injectable). Combined product - not sold separately.

Available Vial Sizes

5mL vial, RDT package, Suspension bottle

Route of Administration

Subcutaneous (SC)

Storage

Refrigerate 2-8°C

Note: CJC-1295 is typically compounded as a combination product with Ipamorelin for enhanced growth hormone release. Please consult with your provider for the most appropriate formulation.

For Patients

Interested in CJC-1295 / Ipamorelin? Connect with our medical team to discuss if this therapy is right for you.

or call us directly:

512-608-9355

For Healthcare Providers

New to Lake Hills Pharmacy? Join our network of providers offering evidence-based peptide therapy to your patients.

Partner with Lake Hills

Quick approval • Access to all formulations

Clinical View: Complete drug monograph with evidence-based protocols. Switch to General View for patient-friendly information.

Important Information About Compounded Medications

These peptides are not FDA-approved but are commonly used by providers and patients under medical supervision. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. We provide evidence-based information from current research to help navigate this evolving field. Our goal is to ensure access to safe, pure, potent products under professional oversight—not unregulated substances purchased online.

Lake Hills Pharmacy | Licensed 503A Compounding Pharmacy | USP 797/800 Compliant | Professional Medical Oversight Required